207940:KRX
Samsung Biologics Co Ltd
1 427 000,00 KRW
0,00%
(0,00) 1D
19-окт., 15:32:30 GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Mkt. cap
69,30 трлн
Avg. vol.
53,12 миң
Volume
0,00
P/E ratio
31,09
52-wk high
1 973 600 KRW
52-wk low
1 110 460 KRW
EPS
45 897 KRW
Shares outstanding
46,29 млн
No. of employees
5 миң
Mkt. cap
69,30 трлн
Avg. vol.
53,12 миң
Volume
0,00
P/E ratio
31,09
52-wk high
1 973 600 KRW
52-wk low
1 110 460 KRW
EPS
45 897 KRW
Shares outstanding
46,29 млн
No. of employees
5 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
23 саат мурун
Samsung Biologics clears 87.88% tender hurdle: what it means for Samsung Biologics stock
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd